Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration
暂无分享,去创建一个
Salomon Y. Cohen | L. Kodjikian | S. Baillif | F. Coscas | H. Oubraham | M. Weber | C. Faure | M. Dominguez | S. Cohen